Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1047 |
---|---|
Product Name | Anti-Human CD19 & CD3E Recombinant Antibody(Blinatumomab) |
Molecular Name | Blinatumomab |
Alias | Anti-CD19 & CD3E Recombinant Antibody, Research Grade Blinatumomab |
CAS Number | 853426-35-4 |
Molecular Weight | 54.1 kDa |
Target | CD19 & CD3E[Homo sapiens] |
Isotype | (scFv Kappa-heavy)-(scFv-heavy Kappa) |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Buffer | PBS, pH7.5 |
Background | Blinatumomab, sold under the brand name Blincyto, is a biopharmaceutical medication used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |